car t cell therapy in relapsed/refractory dlbcl
Published 3 years ago • 231 plays • Length 6:48Download video MP4
Download video MP3
Similar videos
-
2:17
dr. pagel on the utility of car t-cell therapy in relapsed/refractory dlbcl
-
1:12
evaluating the role of car t-cell therapy in relapsed/refractory dlbcl
-
1:38
car t-cell therapy appears promising in relapsed/refractory dlbcl
-
1:26
dr. hill on the role of car t-cell therapy in relapsed/refractory dlbcl
-
3:01
candidates for car t-cell therapy in dlbcl
-
1:29
dr. wang on the utility of car t-cell therapy in relapsed/refractory mcl
-
2:22
dr. leslie on the development of car t-cell therapy in dlbcl and mcl
-
1:12
dr. maloney on the value of car t cells in relapsed/refractory aggressive lymphomas
-
8:43
use of car t therapy in r/r dlbcl
-
1:11
dr. andreadis on car t-cell therapy in relapsed/refractory mcl
-
8:14
safety and efficacy of car t therapy in r/r dlbcl
-
3:12
the role of car t-cell therapy in dlbcl
-
6:38
future directions of car t therapy in r/r dlbcl
-
2:35
when should car-t therapy be considered for relapsed/refractory dlbcl patients?
-
18:12
2022 west oncology conference | treatment sequencing in relapsed/refractory dlbcl in era of car-t
-
6:54
the future of car-t therapy in the management of dlbcl
-
0:48
car t cell options for relapsed/refractory dlbcl
-
6:23
car-t therapy for dlbcl
-
5:04
car-t therapy in patients 75 with relapsed/refractory dlbcl | pierre bories, md, phd | eha 2024